Aandeel 605077 ZHEJIANG HUAKANG PHARMACEUTICAL CO., LTD.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Zhejiang Huakang Pharmaceutical Co., Ltd.

Aandelen

605077

CNE100005477

slotkoers Shanghai S.E.
Andere beurzen
 00:00:00 27-06-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
14,96 CNY -0,60% Intraday-grafiek van Zhejiang Huakang Pharmaceutical Co., Ltd. -2,09% -10,13%
25/04 Zhejiang Huakang Pharmaceutical Co, Ltd. rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2024 CI
18/04 Zhejiang Huakang Pharmaceutical Co, Ltd. Rapporteert winstresultaten voor het volledige jaar eindigend op 31 december 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Certain A Shares of Zhejiang Huakang Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2024.
Zhoushan Huakang Biotechnology Co., Ltd. announced that it expects to receive CNY 700 million in funding from Zhejiang Huakang Pharmaceutical Co., Ltd.
Huakang Pharmaceutical Earmarks 248 Million Yuan for Corn Oil, Maltodextrin Plants
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Zhejiang Huakang Pharmaceutical Co., Ltd.(XSSC:605077) added to S&P Global BMI Index
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
HY Energy Plans to Sell Remaining Stake in Huakang Pharma
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Zhejiang Huakang Pharma Selling 1.3 Billion Yuan Convertible Bonds to Fund New Factory
Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077completed the acquisition of 95% each on Zhejiang Huahe Thermal Power Co., Ltd. and Zhoushan Xinyisheng Trading Co., Ltd. from Ningbo Ruishunjiu Trading Co., Ltd.
Zhejiang Huakang Pharma to Buy 95% of Thermal Power Firm for 522.5 Million Yuan
Zhejiang Huakang Pharmaceutical Co., Ltd. agreed to sign the Equity Transfer Agreement to acquire 95% each on Zhejiang Huahe Thermal Power Co., Ltd. and Zhoushan Xinyisheng Trading Co., Ltd. from Ningbo Ruishunjiu Trading Co., Ltd. for CNY 522.5 million.
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
HY Energy Plans to Unload Stake in Zhejiang Huakang Pharma
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Jiaozuo Huakang Sugar Alcohol Technology Co., Ltd. announced that it expects to receive CNY 295.8671 million in funding from Zhejiang Huakang Pharmaceutical Co., Ltd.
Ningbo Traditional Chinese Pharmaceutical Corp. announced that it has received CNY 21.97644 million in funding from Zhejiang Huakang Pharmaceutical Co., Ltd.
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 605077
  4. Nieuws Zhejiang Huakang Pharmaceutical Co., Ltd.
  5. Andere talen